English

Rapid Micro Biosystems, Inc.

EDGAR

RPID Quarterly report (10-Q) · filed 2026-08-07

Annual consolidated revenue for 2025: about USD 33.59M, using the latest reported figures. The previous period, 2024, was about USD 28.05M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

8.05 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 8054000 USD Source

Operating margin

-152.99%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -12322000 USD Source
Revenue: 8054000 USD Source

Operating cash flow

-12.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -27760000 USD Source
Operating Cash Flow: -15058000 USD Source

Cash and cash equivalents: 14.7 million USD 2026-06-30 Source
Exact value

14687000 USD
Long-term debt including current maturities: 0 USD 2022-12-31 Source
Exact value

0 USD
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

35.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 7838000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 33587000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 22305000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 8002000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 8054000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-51.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -11505000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -47123000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -34626000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -14275000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -12923000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-40.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -27816000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -18765000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -31062000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -27816000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -15058000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -27760000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -15058000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

925 thousand USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Capital expenditure: 685000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 319000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 758000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 685000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 850000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 758000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 394000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-07.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2025-12-31
Operating income: 5 of 11 periods available· newest 2025-12-31
Net income: 5 of 11 periods available· newest 2025-12-31
Operating cash flow: 5 of 11 periods available· newest 2025-12-31
Capital expenditure: 5 of 11 periods available· newest 2025-12-31
Total assets: 5 of 11 periods available· newest 2025-12-31
Total liabilities: 5 of 11 periods available· newest 2025-12-31
Current assets: 5 of 11 periods available· newest 2025-12-31
Current liabilities: 5 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.7%

Prior period

USD 28.05 million

2024-01-01 – 2024-12-31
Current period

USD 33.59 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

33587000 − 28051000 = 5536000 USD

28051000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
33587000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Year-over-year change in Revenue: 5536000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 33587000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1281255 Filing: 000138010626000034 Input fundies:Revenue: 28051000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1282229 Filing: 000138010626000034
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 234,000

Prior period

−USD 46.89 million

2024-01-01 – 2024-12-31
Current period

−USD 47.12 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-47123000 − -46889000 = -234000 USD

-46889000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-47123000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Year-over-year change in Net income: -234000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -47123000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1673175 Filing: 000138010626000034 Input fundies:NetIncome: -46889000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1673948 Filing: 000138010626000034
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 13.09 million

Prior period

−USD 44.15 million

2024-01-01 – 2024-12-31
Current period

−USD 31.06 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-31062000 − -44153000 = 13091000 USD

-44153000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-31062000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Year-over-year change in Operating cash flow: 13091000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31062000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1136517 Filing: 000138010626000034 Input fundies:OperatingCashFlow: -44153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1137168 Filing: 000138010626000034
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-37.7%

Prior period

USD 1.37 million

2024-01-01 – 2024-12-31
Current period

USD 850,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

850000 − 1365000 = -515000 USD

1365000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
850000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Year-over-year change in Capital expenditure: -515000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 850000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1138810 Filing: 000138010626000034 Input fundies:CapitalExpenditure: 1365000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1139368 Filing: 000138010626000034
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 33.59 million 100% of revenue
Operating costs Derived USD 80.98 million 241% of revenue
Operating income −USD 47.39 million −141% of revenue
Tax, interest and other Derived −USD 269,000 −0.8% of revenue
Net income −USD 47.12 million −140% of revenue

Cash

Operating cash flow −USD 31.06 million −92% of revenue
Capital expenditure USD 850,000 2.5% of revenue
Free cash flow Derived −USD 31.91 million −95% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2021 Operating loss: operating costs were 303% of revenue.
2022 Operating loss: operating costs were 469% of revenue.
2023 Operating loss: operating costs were 351% of revenue.
2024 Operating loss: operating costs were 278% of revenue.
2025 Operating loss: operating costs were 241% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2021 2021-01-01 – 2021-12-31	23232000	70464000 Derived	-47232000	26292000 Derived	-73524000	-58181000 Derived	Source 2021-01-01 – 2021-12-31: 23232000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -47232000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -73524000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -54964000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 3217000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	17133000	80352000 Derived	-63219000	-2413000 Derived	-60806000	-65287000 Derived	Source 2022-01-01 – 2022-12-31: 17133000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -63219000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -60806000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -58547000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 6740000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	22519000	79082000 Derived	-56563000	-4096000 Derived	-52467000	-46926000 Derived	Source 2023-01-01 – 2023-12-31: 22519000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -56563000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -52467000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -45081000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1845000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	28051000	77970000 Derived	-49919000	-3030000 Derived	-46889000	-45518000 Derived	Source 2024-01-01 – 2024-12-31: 28051000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -49919000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -46889000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -44153000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1365000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	33587000	80979000 Derived	-47392000	-269000 Derived	-47123000	-31912000 Derived	Source 2025-01-01 – 2025-12-31: 33587000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -47392000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -47123000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -31062000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 850000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 33.6M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Revenue	23232000	Revenue: 23232000 Open source
20222022-12-31	Revenue	17133000	Revenue: 17133000 Open source
20232023-12-31	Revenue	22519000	Revenue: 22519000 Open source
20242024-12-31	Revenue	28051000	Revenue: 28051000 Open source
20252025-12-31	Revenue	33587000	Revenue: 33587000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Year over year	No prior comparable period	Revenue: 23232000 Open source
20222022-12-31	Year over year	-26.3%	Revenue: 17133000 Open source Revenue: 23232000 Open source
20232023-12-31	Year over year	31.4%	Revenue: 22519000 Open source Revenue: 17133000 Open source
20242024-12-31	Year over year	24.6%	Revenue: 28051000 Open source Revenue: 22519000 Open source
20252025-12-31	Year over year	19.7%	Revenue: 33587000 Open source Revenue: 28051000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -141.1% 2025

Net margin -140.3% 2025

Free cash flow margin -95% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Operating margin	-203.3%	Operating Income: -47232000 Open source Revenue: 23232000 Open source
20222022-12-31	Operating margin	-369%	Operating Income: -63219000 Open source Revenue: 17133000 Open source
20232023-12-31	Operating margin	-251.2%	Operating Income: -56563000 Open source Revenue: 22519000 Open source
20242024-12-31	Operating margin	-178%	Operating Income: -49919000 Open source Revenue: 28051000 Open source
20252025-12-31	Operating margin	-141.1%	Operating Income: -47392000 Open source Revenue: 33587000 Open source
20212021-12-31	Net margin	-316.5%	Net Income: -73524000 Open source Revenue: 23232000 Open source
20222022-12-31	Net margin	-354.9%	Net Income: -60806000 Open source Revenue: 17133000 Open source
20232023-12-31	Net margin	-233%	Net Income: -52467000 Open source Revenue: 22519000 Open source
20242024-12-31	Net margin	-167.2%	Net Income: -46889000 Open source Revenue: 28051000 Open source
20252025-12-31	Net margin	-140.3%	Net Income: -47123000 Open source Revenue: 33587000 Open source
20212021-12-31	Free cash flow margin	-250.4%	Revenue: 23232000 Open source Operating Cash Flow: -54964000 Open source Capital Expenditure: 3217000 Open source
20222022-12-31	Free cash flow margin	-381.1%	Revenue: 17133000 Open source Operating Cash Flow: -58547000 Open source Capital Expenditure: 6740000 Open source
20232023-12-31	Free cash flow margin	-208.4%	Revenue: 22519000 Open source Operating Cash Flow: -45081000 Open source Capital Expenditure: 1845000 Open source
20242024-12-31	Free cash flow margin	-162.3%	Revenue: 28051000 Open source Operating Cash Flow: -44153000 Open source Capital Expenditure: 1365000 Open source
20252025-12-31	Free cash flow margin	-95%	Revenue: 33587000 Open source Operating Cash Flow: -31062000 Open source Capital Expenditure: 850000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -31.1M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Operating cash flow	-54964000	Operating Cash Flow: -54964000 Open source
20222022-12-31	Operating cash flow	-58547000	Operating Cash Flow: -58547000 Open source
20232023-12-31	Operating cash flow	-45081000	Operating Cash Flow: -45081000 Open source
20242024-12-31	Operating cash flow	-44153000	Operating Cash Flow: -44153000 Open source
20252025-12-31	Operating cash flow	-31062000	Operating Cash Flow: -31062000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -31.9M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Free cash flow	-58181000	Operating Cash Flow: -54964000 Open source Capital Expenditure: 3217000 Open source
20222022-12-31	Free cash flow	-65287000	Operating Cash Flow: -58547000 Open source Capital Expenditure: 6740000 Open source
20232023-12-31	Free cash flow	-46926000	Operating Cash Flow: -45081000 Open source Capital Expenditure: 1845000 Open source
20242024-12-31	Free cash flow	-45518000	Operating Cash Flow: -44153000 Open source Capital Expenditure: 1365000 Open source
20252025-12-31	Free cash flow	-31912000	Operating Cash Flow: -31062000 Open source Capital Expenditure: 850000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

55.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Liabilities / assets	8.4%	Total Liabilities: 20189000 Open source Total Assets: 241169000 Open source
20222022-12-31	Liabilities / assets	13.9%	Total Liabilities: 26481000 Open source Total Assets: 190650000 Open source
20232023-12-31	Liabilities / assets	17.8%	Total Liabilities: 25463000 Open source Total Assets: 143452000 Open source
20242024-12-31	Liabilities / assets	23.2%	Total Liabilities: 22817000 Open source Total Assets: 98169000 Open source
20252025-12-31	Liabilities / assets	55.6%	Total Liabilities: 41646000 Open source Total Assets: 74852000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.31× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Current assets / current liabilities	12.01×	Current Assets: 218124000 Open source Current Liabilities: 18166000 Open source
20222022-12-31	Current assets / current liabilities	7.27×	Current Assets: 138576000 Open source Current Liabilities: 19050000 Open source
20232023-12-31	Current assets / current liabilities	6.34×	Current Assets: 120415000 Open source Current Liabilities: 18986000 Open source
20242024-12-31	Current assets / current liabilities	4.61×	Current Assets: 80917000 Open source Current Liabilities: 17565000 Open source
20252025-12-31	Current assets / current liabilities	3.31×	Current Assets: 61168000 Open source Current Liabilities: 18487000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2021 2021-01-01 – 2021-12-31	−USD 73.52 million Exact value Exact value: -73524000 USD 2021-01-01 – 2021-12-31: -73524000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rapid Micro Biosystems, Inc. · 2021-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Net Income: -73524000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -73524000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010623000016/rmb-20221231.htm#2224244 Filing: 000138010623000016 The citation records this snapshot. The page link may show a newer release later.	−USD 54.96 million Exact value Exact value: -54964000 USD 2021-01-01 – 2021-12-31: -54964000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rapid Micro Biosystems, Inc. · 2021-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Operating Cash Flow: -54964000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54964000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010623000016/rmb-20221231.htm#1398097 Filing: 000138010623000016 The citation records this snapshot. The page link may show a newer release later.	USD 3.22 million Exact value Exact value: 3217000 USD 2021-01-01 – 2021-12-31: 3217000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rapid Micro Biosystems, Inc. · 2021-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Capital Expenditure: 3217000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3217000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010623000016/rmb-20221231.htm#1401157 Filing: 000138010623000016 The citation records this snapshot. The page link may show a newer release later.	−USD 58.18 million Calculation and evidence -54964000 − 3217000 USD Exact free cash flow: -58181000 USD 2021-01-01 – 2021-12-31: -54964000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3217000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rapid Micro Biosystems, Inc. · 2021-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Free cash flow: -58181000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -54964000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010623000016/rmb-20221231.htm#1398097 Filing: 000138010623000016 Input fundies:CapitalExpenditure: 3217000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010623000016/rmb-20221231.htm#1401157 Filing: 000138010623000016 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 60.81 million Exact value Exact value: -60806000 USD 2022-01-01 – 2022-12-31: -60806000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rapid Micro Biosystems, Inc. · 2022-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Net Income: -60806000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60806000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010624000073/rmb-20231231.htm#1586229 Filing: 000138010624000073 The citation records this snapshot. The page link may show a newer release later.	−USD 58.55 million Exact value Exact value: -58547000 USD 2022-01-01 – 2022-12-31: -58547000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rapid Micro Biosystems, Inc. · 2022-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Operating Cash Flow: -58547000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58547000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010624000073/rmb-20231231.htm#1085941 Filing: 000138010624000073 The citation records this snapshot. The page link may show a newer release later.	USD 6.74 million Exact value Exact value: 6740000 USD 2022-01-01 – 2022-12-31: 6740000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rapid Micro Biosystems, Inc. · 2022-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Capital Expenditure: 6740000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6740000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010624000073/rmb-20231231.htm#1088192 Filing: 000138010624000073 The citation records this snapshot. The page link may show a newer release later.	−USD 65.29 million Calculation and evidence -58547000 − 6740000 USD Exact free cash flow: -65287000 USD 2022-01-01 – 2022-12-31: -58547000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 6740000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rapid Micro Biosystems, Inc. · 2022-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Free cash flow: -65287000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58547000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010624000073/rmb-20231231.htm#1085941 Filing: 000138010624000073 Input fundies:CapitalExpenditure: 6740000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010624000073/rmb-20231231.htm#1088192 Filing: 000138010624000073 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 52.47 million Exact value Exact value: -52467000 USD 2023-01-01 – 2023-12-31: -52467000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rapid Micro Biosystems, Inc. · 2023-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Net Income: -52467000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52467000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000058/rmb-20241231.htm#1614583 Filing: 000138010625000058 The citation records this snapshot. The page link may show a newer release later.	−USD 45.08 million Exact value Exact value: -45081000 USD 2023-01-01 – 2023-12-31: -45081000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rapid Micro Biosystems, Inc. · 2023-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Operating Cash Flow: -45081000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45081000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000058/rmb-20241231.htm#1132406 Filing: 000138010625000058 The citation records this snapshot. The page link may show a newer release later.	USD 1.85 million Exact value Exact value: 1845000 USD 2023-01-01 – 2023-12-31: 1845000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rapid Micro Biosystems, Inc. · 2023-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Capital Expenditure: 1845000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1845000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000058/rmb-20241231.htm#1134657 Filing: 000138010625000058 The citation records this snapshot. The page link may show a newer release later.	−USD 46.93 million Calculation and evidence -45081000 − 1845000 USD Exact free cash flow: -46926000 USD 2023-01-01 – 2023-12-31: -45081000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1845000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rapid Micro Biosystems, Inc. · 2023-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Free cash flow: -46926000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45081000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000058/rmb-20241231.htm#1132406 Filing: 000138010625000058 Input fundies:CapitalExpenditure: 1845000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010625000058/rmb-20241231.htm#1134657 Filing: 000138010625000058 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 46.89 million Exact value Exact value: -46889000 USD 2024-01-01 – 2024-12-31: -46889000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rapid Micro Biosystems, Inc. · 2024-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Net Income: -46889000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46889000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1673948 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	−USD 44.15 million Exact value Exact value: -44153000 USD 2024-01-01 – 2024-12-31: -44153000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rapid Micro Biosystems, Inc. · 2024-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Operating Cash Flow: -44153000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1137168 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	USD 1.37 million Exact value Exact value: 1365000 USD 2024-01-01 – 2024-12-31: 1365000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rapid Micro Biosystems, Inc. · 2024-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Capital Expenditure: 1365000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1365000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1139368 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	−USD 45.52 million Calculation and evidence -44153000 − 1365000 USD Exact free cash flow: -45518000 USD 2024-01-01 – 2024-12-31: -44153000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1365000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rapid Micro Biosystems, Inc. · 2024-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Free cash flow: -45518000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1137168 Filing: 000138010626000034 Input fundies:CapitalExpenditure: 1365000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1139368 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 47.12 million Exact value Exact value: -47123000 USD 2025-01-01 – 2025-12-31: -47123000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Net Income: -47123000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47123000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1673175 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	−USD 31.06 million Exact value Exact value: -31062000 USD 2025-01-01 – 2025-12-31: -31062000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Operating Cash Flow: -31062000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31062000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1136517 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	USD 850,000 Exact value Exact value: 850000 USD 2025-01-01 – 2025-12-31: 850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Capital Expenditure: 850000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 850000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1138810 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.	−USD 31.91 million Calculation and evidence -31062000 − 850000 USD Exact free cash flow: -31912000 USD 2025-01-01 – 2025-12-31: -31062000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Rapid Micro Biosystems, Inc. · 2025-12-31 Rapid Micro Biosystems, Inc. (edgar:1380106) Free cash flow: -31912000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1380106?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31062000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1136517 Filing: 000138010626000034 Input fundies:CapitalExpenditure: 850000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1380106/000138010626000034/rmb-20251231.htm#1138810 Filing: 000138010626000034 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 2,108 latest values · 2,108 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001380106, 1380106, RPID, edgar:1380106

Also known as RAPID MICRO BIOSYSTEMS INC, RAPID MICRO BIOSYSTEMS, INC., Rapid Micro Biosystems, Inc., Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation